Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.
Not Applicable
Completed
- Conditions
- Symmetric Limited Morphea
- Registration Number
- NCT00812188
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Brief Summary
Compare UVA-1 phototherapy treatment to topical steroid treatment in subjects with morphea.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
- Male and female subjects 18 years of age or older.
- Symmetric limited morphea.
Exclusion Criteria
- Known sensitivity to fluocinonide 0.05% cream.
- Clinical evidence of superinfected skin.
- Immunocompromised state (including previously documented HIV).
- Generalized Scleroderma.
- Previous history of skin cancer.
- Non-English speaking subjects.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Efficacy of UVA-1 treatment vs. topical steroid. 5 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UT Southwestern Medical Center at Dallas - Department of Dermatology Clinical Trials
🇺🇸Dallas, Texas, United States
UT Southwestern Medical Center at Dallas - Department of Dermatology Clinical Trials🇺🇸Dallas, Texas, United States